Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Single Arm Study of Efficacy and Safety of P1101 for Polycythemia Vera (PV) Patients for Whom the Current Standard of Treatment is Difficult to Apply

NCT04182100 is registered in ClinicalTrials.gov with PharmaEssentia Japan K.K. as lead sponsor.

NCT NCT04182100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04182100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Single Arm Study of Efficacy and Safety of P1101 for Polycythemia Vera (PV) Patients for Whom the Current Standard of Treatment is Difficult to Apply
Lead sponsor
PharmaEssentia Japan K.K.
Phase
Phase 2
Overall status
Completed
Start date
December 20, 2019
Completion date
March 8, 2021
Enrollment
29 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

polycythemia vera (pv)